Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1991 5
1992 2
1993 3
1994 1
1996 2
1997 5
1998 4
1999 3
2001 6
2002 7
2003 10
2004 3
2005 11
2006 9
2007 7
2008 8
2009 11
2010 20
2011 24
2012 15
2013 25
2014 28
2015 18
2016 13
2017 22
2018 17
2019 27
2020 30
2021 37
2022 32
2023 32
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

394 results

Results by year

Filters applied: . Clear all
Page 1
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, Negrier S, Ou YC, Castellano D, Lim HY, Uemura H, Tarazi J, Cella D, Chen C, Rosbrook B, Kim S, Motzer RJ. Rini BI, et al. Among authors: ou yc. Lancet. 2011 Dec 3;378(9807):1931-9. doi: 10.1016/S0140-6736(11)61613-9. Epub 2011 Nov 4. Lancet. 2011. PMID: 22056247 Clinical Trial.
Cancer Immunoimaging with Smart Nanoparticles.
Ou YC, Wen X, Bardhan R. Ou YC, et al. Trends Biotechnol. 2020 Apr;38(4):388-403. doi: 10.1016/j.tibtech.2019.11.001. Epub 2019 Dec 5. Trends Biotechnol. 2020. PMID: 31812371 Review.
Urologic cancer in Taiwan.
Hung CF, Yang CK, Ou YC. Hung CF, et al. Among authors: ou yc. Jpn J Clin Oncol. 2016 Jul;46(7):605-9. doi: 10.1093/jjco/hyw038. Epub 2016 Apr 6. Jpn J Clin Oncol. 2016. PMID: 27052114 Review.
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.
Cha TL, Wu TT, Vogelzang NJ, Huang CY, Huang SP, Lin CC, Ou YC, Pang ST, Shen DH, Wu WJ, Chang WY. Cha TL, et al. Among authors: ou yc. J Formos Med Assoc. 2017 Nov;116(11):825-836. doi: 10.1016/j.jfma.2017.04.005. Epub 2017 Oct 16. J Formos Med Assoc. 2017. PMID: 29046247 Free article. Review.
394 results